Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
---|
06/10/2010 | US20100144588 Proton acceptor iminium/carbocation-type coupling agents |
06/10/2010 | CA2745121A1 Morpholinone compounds as factor ixa inhibitors |
06/09/2010 | EP2193781A1 Hair dye and hair dye composition |
06/09/2010 | CN1662511B Pharmaceutical salts of reboxetine |
06/08/2010 | US7732449 preferential enzyme Inhibitors such as 4-(4-Acetyl-piperazin-1-yl)-2-(R)-cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-butyramide, used for the treatment of inflammation, arthritis and atherosclerosis |
06/08/2010 | US7732443 Prostaglandin derivatives useful in treating vision defects, inflammatory bowel disease and alopecia |
06/08/2010 | US7732435 vanilloid receptor antagonists such as 7-(4-Chlorophenyl)-6-isopropyl-3-methyl-2,3-dihydro-1H-1-aza-4,5-dioxa-phenanthren-8-one, used for treating nociceptive pain; analgesics |
06/03/2010 | WO2010062536A2 Modified actinomycin-based nucleic acid stains and methods of their use |
06/03/2010 | US20100137583 Peptidomimetic protease inhibitors |
06/03/2010 | US20100137316 Morpholine Compounds, Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Compositions, and Methods Of Use Thereof |
06/03/2010 | US20100137296 N-phenyl anthranilic acid derivatives and uses thereof |
06/03/2010 | US20100137290 Oxazolidinone antibiotic derivatives |
06/03/2010 | US20100137194 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism |
06/03/2010 | US20100133992 Compound comprising phosphorescence unit, emitting polymer and organic emitting device comprising the emitting polymer |
06/02/2010 | EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone |
06/02/2010 | EP1483228B1 Nk1 antagonists |
06/01/2010 | US7728027 reacting 2-bromo-1-[4-[4-(2-bromoacetyl)phenyl]phenyl]ethanone with 1-(tert-butoxycarbonyl)-L-proline, then treating the product with ammonium acetate and deprotection to form chemical intermediates for viricides; cost efficiency; industrial scale |
06/01/2010 | US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
06/01/2010 | US7727985 For therapy of inflammatory disease and cancer |
06/01/2010 | US7727984 Medicaments for the treatment of chronic obstructive pulmonary disease |
05/27/2010 | WO2010032259A3 Process for the preparation of efavirenz |
05/27/2010 | WO2010026110A3 6-substituted benzoxazines as 5-ht-5a receptor antagonists |
05/27/2010 | WO2010019911A3 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
05/27/2010 | US20100130486 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
05/27/2010 | US20100130484 Novel bicyclic sulfonamide derivatives which are l-cpt1 inhibitors |
05/27/2010 | US20100130471 Renin Inhibitors |
05/26/2010 | EP2189451A1 Benzamide derivatives, their preparation and uses in medicine thereof |
05/26/2010 | EP2187888A2 Bicyclic amides for enhancing glutamatergic synaptic responses |
05/26/2010 | EP1438352B1 Low color, low sodium benzoxazinone uv absorbers and process for making same |
05/26/2010 | CN1910137B Aryl aniline derivatives as beta2 adrenergic receptor agonists |
05/26/2010 | CN1391469B Npyy5拮抗剂 Npyy5 antagonist |
05/26/2010 | CN101110478B Electrode for fuel cell and fuel cell employing the electrode |
05/25/2010 | US7723327 Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
05/25/2010 | US7723326 Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
05/25/2010 | US7722893 Use of substitute 2,4-bis (alkylamino) pyrimidines or quinzolines as antimicrobials |
05/25/2010 | CA2440518C Method of producing n-substituted 2,6-dialkyl morpholines |
05/20/2010 | WO2010056320A2 Pi3k/mtor kinase inhibitors |
05/20/2010 | US20100125070 Bupropion Metabolites and Methods of Their Synthesis and Use |
05/20/2010 | US20100125069 Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds |
05/20/2010 | CA2743015A1 Pi3k/mtor kinase inhibitors |
05/18/2010 | US7718653 Pyrimidine derivatives for inhibiting Eph receptors |
05/13/2010 | US20100119709 Organic colorants and compositions containing same |
05/12/2010 | EP2183229A1 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
05/12/2010 | EP2183228A1 CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1 |
05/12/2010 | CN101704796A Preparation method of 3-morpholone |
05/12/2010 | CN101704795A Hydrochloric acid 2-(1-ethyl propyl) moroxydine, preparation method and application thereof |
05/11/2010 | US7714012 Synthesis and biological activities of new tricyclic-bis-enones (TBEs) |
05/11/2010 | US7713968 Substituted arylcyclopentenes as therapeutic agents |
05/11/2010 | US7713967 Therapeutic substituted hydantoins, and related compounds |
05/11/2010 | US7713966 Heterobicyclic metalloprotease inhibitors |
05/11/2010 | US7713963 Acylated indanyl amines and their use as pharmaceuticals |
05/06/2010 | WO2010050781A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
05/06/2010 | WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
05/06/2010 | WO2010049302A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists |
05/06/2010 | US20100113778 Process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation |
05/06/2010 | US20100113770 O-substituted hydroxyaryl derivatives |
05/06/2010 | US20100113438 Class of histone deacetylase inhibitors |
05/06/2010 | US20100113418 Heterocyclic compound |
05/06/2010 | CA2779178A1 Analgesic that binds filamin a |
05/06/2010 | CA2741153A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists |
05/04/2010 | US7709474 Enantiomerically pure beta agonists, manufacturing and use thereof |
05/04/2010 | US7709472 treating bacterial infections; 6-{[((1S,5R,6S)-3-{2-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-azabicyclo[3.2.0]hept-6-yl)amino]methyl}-2H-pyrido[3,2-b][1,4]-thiazin-3(4H)-one or -oxazin-3(4H)-one; antibiotics; grampositive Staphylococcus, gramnegative Haemophilus, Moraxella, Escherichia |
04/29/2010 | US20100105894 Cyclopropane compounds and pharmaceutical use thereof |
04/29/2010 | US20100105671 C7-fluoro substituted tetracycline compounds |
04/29/2010 | US20100105642 Novel compounds 409 |
04/29/2010 | US20100105095 Optical Molecular Sensors for Cytochrome P450 Activity |
04/29/2010 | US20100104979 Alpha-hydroxyketones |
04/28/2010 | EP2179994A1 Fused bicyclic compound |
04/28/2010 | EP1363640B1 Nucleic acid derivatives |
04/28/2010 | CN1658855B O-substituted hydroxyaryl derivatives |
04/27/2010 | US7705008 Prostaglandin analogs |
04/27/2010 | US7705001 Therapeutic substituted gamma lactams |
04/27/2010 | US7704995 Protein kinase modulators and methods of use |
04/27/2010 | CA2493667C Vanilloid receptor ligands and their use in treatments |
04/22/2010 | WO2010043592A1 Lipase inhibitors for use for the treatment of obesity |
04/22/2010 | US20100099867 Process for the preparation of tiotropium bromide |
04/22/2010 | US20100099621 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
04/22/2010 | US20100098630 Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides |
04/22/2010 | DE102008052618A1 Tricyclische Aldehyde und C,H-acide Verbindungen The tricyclic aldehydes and C, H-acidic compounds |
04/21/2010 | EP2177513A1 Phenylacetic acid compound |
04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
04/21/2010 | CN101265322B Preparation method of cyano-containing benzoxazine resin |
04/20/2010 | US7700591 to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
04/20/2010 | US7700590 Antibacterial agents |
04/20/2010 | US7700584 antitumor agents; viricides |
04/20/2010 | CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien |
04/15/2010 | WO2010042925A2 Compositions and methods for treating alcohol use disorders, pain and other diseases |
04/15/2010 | WO2010042867A2 Activators of human pyruvate kinase |
04/15/2010 | WO2010042475A1 Spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
04/15/2010 | US20100094001 Composition containing stability-improved chloromethyl phosphate derivative and process for producing same |
04/15/2010 | US20100093713 Beta-carbolines useful for treating inflammatory disease |
04/15/2010 | US20100093707 Acid amide derivatives, process for their production and pesticides containing them |
04/15/2010 | CA2740148A1 Activators of human pyruvate kinase |
04/14/2010 | EP1805170B1 Mif-inhibitors |
04/14/2010 | EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof |
04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
04/13/2010 | US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
04/13/2010 | US7696205 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
04/13/2010 | US7696201 e.g. ethyl-4-((2-oxo-1,2-dihydrospiro[benzo[d]1,3]oxazine-4,4'-piperidine]-1'-yl)methyl)piperidine-1-carboxylate; central nervous system disorders; natidepressant, cognition activator, neurodegenerative diseases; obesity, Alzheimer's disease, psychosis, schizophrenia, mania, bipolar disorders |
04/13/2010 | US7696200 4-{[4-(5-Chloro-2-methoxy-benzenesulfonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-6-carbonyl]-amino}-benzoic acid; Type II diabetes; carnitine-dependent palmitoyltransferases (CPTs) |